z-logo
open-access-imgOpen Access
Multiplex degenerate PCR coupled with an oligo sorbent array for human endogenous retrovirus expression profiling
Author(s) -
Jean-Philippe Pichon,
Bertrand Bonnaud,
Philippe Cleuziat,
François Mallet
Publication year - 2006
Publication title -
nucleic acids research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 9.008
H-Index - 537
eISSN - 1362-4954
pISSN - 0305-1048
DOI - 10.1093/nar/gkl086
Subject(s) - biology , endogenous retrovirus , primer (cosmetics) , microbiology and biotechnology , multiplex polymerase chain reaction , multiplex , in silico pcr , primer extension , gene , genetics , polymerase chain reaction , virology , genome , messenger rna , chemistry , organic chemistry
Human endogenous retroviruses (HERVs) can be divided into distinct families of tens to thousands of paralogous loci. The expression of HERV elements has been detected in all tissues tested to date, particularly germ cells, embryonic tissues and neoplastic tissues. Hence, the study of HERV expression could represent added value in cancer diagnosis. We developed a quantitative assay combining a multiplex degenerate PCR (MD-PCR) amplification, based on the relative conservation of the pol genes, and a colorimetric Oligo Sorbent Array (OLISA). Nine HERV families were selected and amplification primers and capture probes were designed for each family. The features required to achieve efficient amplification of most of the elements of each HERV family and balanced co-amplification of all HERV families were analyzed. We found that MD-PCR reliability, i.e. equivalence of amplification and dose-effect relationship, relied on the adjustment of three critical parameters: the primer degeneracy, the relative concentration of each primer and the total amount of primers in the amplification mixture. The analysis of tumoral versus normal tissues suggests that this assay could prove useful in tumor phenotyping.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here